180 related articles for article (PubMed ID: 8103709)
1. Differential effects of tyrosine kinase inhibition in CD69 antigen expression and lytic activity induced by rIL-2, rIL-12, and rIFN-alpha in human NK cells.
Gerosa F; Tommasi M; Benati C; Gandini G; Libonati M; Tridente G; Carra G; Trinchieri G
Cell Immunol; 1993 Sep; 150(2):382-90. PubMed ID: 8103709
[TBL] [Abstract][Full Text] [Related]
2. Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases.
Borrego F; Peña J; Solana R
Eur J Immunol; 1993 May; 23(5):1039-43. PubMed ID: 8477800
[TBL] [Abstract][Full Text] [Related]
3. The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation.
Nagler A; Lanier LL; Phillips JH
J Immunol; 1988 Oct; 141(7):2349-51. PubMed ID: 3262658
[TBL] [Abstract][Full Text] [Related]
4. Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets.
Lebow LT; Jewett A; Bonavida B
J Immunol; 1993 Jan; 150(1):320-9. PubMed ID: 8417130
[TBL] [Abstract][Full Text] [Related]
5. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).
Itoh K; Shiiba K; Shimizu Y; Suzuki R; Kumagai K
J Immunol; 1985 May; 134(5):3124-9. PubMed ID: 2984283
[TBL] [Abstract][Full Text] [Related]
6. Different sensitivity to interleukin 4 of interleukin 2- and interferon alpha-induced CD69 antigen expression in human resting NK cells and CD3+, CD4-, CD8- lymphocytes.
Gerosa F; Tommasi M; Carra G; Gandini G; Tridente G; Benati C
Cell Immunol; 1992 May; 141(2):342-51. PubMed ID: 1533569
[TBL] [Abstract][Full Text] [Related]
7. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
Lanier LL; Benike CJ; Phillips JH; Engleman EG
J Immunol; 1985 Feb; 134(2):794-801. PubMed ID: 3871216
[TBL] [Abstract][Full Text] [Related]
8. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
Itoh K; Tilden AB; Balch CM
J Immunol; 1986 May; 136(10):3910-5. PubMed ID: 3084648
[TBL] [Abstract][Full Text] [Related]
9. Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.
Vandenberghe P; Verwilghen J; Van Vaeck F; Ceuppens JL
Immunology; 1993 Feb; 78(2):210-7. PubMed ID: 7682535
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.
Ostensen ME; Thiele DL; Lipsky PE
J Immunol; 1987 Jun; 138(12):4185-91. PubMed ID: 3108384
[TBL] [Abstract][Full Text] [Related]
11. Costimulatory signals are required for optimal proliferation of human natural killer cells.
Robertson MJ; Manley TJ; Donahue C; Levine H; Ritz J
J Immunol; 1993 Mar; 150(5):1705-14. PubMed ID: 7679691
[TBL] [Abstract][Full Text] [Related]
12. Lymphokine-activated effector cells: modulation of activity by cytokines.
Mehta S; Flanagan P; Blackinton D; Wanebo H
Lymphokine Cytokine Res; 1992 Apr; 11(2):73-7. PubMed ID: 1581419
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
14. Effects of biological response modifiers on lung natural killer activity.
Lauzon W; Lemaire I
Immunopharmacol Immunotoxicol; 1991; 13(3):237-50. PubMed ID: 1719060
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of Fc gamma receptor IIIA alpha (CD16-II) on natural killer cells induced by anti-CD16 mAb is independent of protein tyrosine kinases and protein kinase C.
Borrego F; Lopez-Beltran A; Peña J; Solana R
Cell Immunol; 1994 Oct; 158(1):208-17. PubMed ID: 8087866
[TBL] [Abstract][Full Text] [Related]
16. Changes in gene expression associated with IFN-beta and IL-2-induced augmentation of human natural killer cell function.
Kornbluth J; Hoover RG
J Immunol; 1988 Nov; 141(9):3234-40. PubMed ID: 3049820
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the costimulatory role of IL-2 and IL-15 in initiating proliferation of resting (CD56dim) human NK cells.
Warren HS; Kinnear BF; Kastelein RL; Lanier LL
J Immunol; 1996 May; 156(9):3254-9. PubMed ID: 8617947
[TBL] [Abstract][Full Text] [Related]
18. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
Condiotti R; Nagler A
Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
20. Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer (LAK) activity.
Brooks B; Rees RC
Clin Exp Immunol; 1988 Nov; 74(2):162-5. PubMed ID: 3265652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
